AKERO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 Mar 2026)
What this means for you
Registered since 22 Dec 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Dec 2030: the §8 & §9 renewal).
Record
- Serial number
- 88979629
- Registration number
- 6228033
- Mark type
- Word mark
- Filed
- 22 Aug 2018
- Published for opposition
- 06 Aug 2019
- Registered
- 22 Dec 2020
- Next maintenance filing
- §8 & §9 renewal, due by 22 Dec 2030 (grace period to 22 Jun 2031)
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals; clinical research in the field of pharmaceuticals
Owner
- Akero Therapeutics, Inc., South San Francisco, CA, US
- Akero Therapeutics, Inc., South San Francisco, CA, US
- Akero Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 30 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Mar 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jan 2026 — TEAS SECTION 8 & 15 RECEIVED
- 22 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Jun 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Jun 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 01 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Dec 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Dec 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 19 Nov 2020 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 28 Sept 2020 — NOTICE OF ALLOWANCE CANCELLED
- 19 Nov 2020 — DIVISIONAL PROCESSING COMPLETE